MyFinsight
Home
Blog
About
Back
Cash Flow
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
source: myfinsight.com
Net increase
(decrease) in cash and cash...
-$2,300,271
(26.10%↑ Y/Y)
Accounts payable
$278,451
(118.13%↑ Y/Y)
Stock-based compensation
expense
$214,565
(-83.68%↓ Y/Y)
Prepaid expenses and
other current assets
-$148,775
(53.43%↑ Y/Y)
Proceeds from exercise of
common stock...
$30
(-99.99%↓ Y/Y)
Net cash used in
operating activities
-$2,115,402
(83.98%↑ Y/Y)
Net cash provided by
financing activities
-$184,869
(-101.83%↓ Y/Y)
Canceled cashflow
$641,791
Canceled cashflow
$30
Net loss
-$2,447,831
(80.40%↑ Y/Y)
Proceeds from issuance of
common stock, common...
-$93,827
(-101.02%↓ Y/Y)
Repayment of short-term
debt
$87,181
(-74.72%↓ Y/Y)
Proceeds from issuance of
common stock in atm...
-$3,891
(-100.39%↓ Y/Y)
Accrued expenses and
other current...
-$279,362
(76.37%↑ Y/Y)
Prepaid clinical trial
costs (current and...
$30,000
(106.88%↑ Y/Y)
Back